CVE-2021-23233 - CVE House
Back to Database
Status published High CVE-2021-23233

Fresenius Kabi Agilia Connect Infusion System

Vulnerability Description

Sensitive endpoints in Fresenius Kabi Agilia Link+ v3.0 and prior can be accessed without any authentication information such as the session cookie. An attacker can send requests to sensitive endpoints as an unauthenticated user to perform critical actions or modify critical configuration parameters.

Impact Analysis

Refer to official advisory for detailed impact metrics.

Remediation

Ensure systems are updated to the latest vendor-supplied patch levels.

THREAT MONITOR

Am I Vulnerable?

Launch our assessment wizard to check if your infrastructure is exposed to • CVE-2021-23233

Credits & Attribution

The following person or organization is credited with identifying this vulnerability, as recorded in the NVD database:

  • Julian Suleder (ERNW Research GmbH), Nils Emmerich (ERNW Research GmbH), Raphael Pavlidis (ERNW Research GmbH), and Dr. Oliver Matula (ERNW Enno Rey Netzwerke GmbH) reported these vulnerabilities to the German Federal Office for Information Security (BSI) in the context of the BSI project ManiMed (Medical Device Manipulation Project).

Affected Vendor

Fresenius Kabi

View all reports →

Affected Software

Agilia Link+
Vulnerable Versions:
unspecified

Timeline

Official Publish: January 21st, 2022
Last Modified: April 16th, 2025
Added to House: July 21st, 2026

CVSS Vectors

V3: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L

Weaknesses (CWE)